{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:53:54Z","timestamp":1790823234366,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009854","name":"Duquesne University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019288","name":"Office of Research, University of Kansas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019288","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejpb.2022.10.011","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T13:45:31Z","timestamp":1666014331000},"page":"238-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Lipidoid nanoparticles increase ATP uptake into hypoxic brain endothelial cells"],"prefix":"10.1016","volume":"180","author":[{"given":"Purva","family":"Khare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devika","family":"S Manickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2022.10.011_b0005","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jconrel.2019.10.028","article-title":"Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening","volume":"316","author":"Guimaraes","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2022.10.011_b0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","article-title":"Lipid nanoparticles for delivery of messenger RNA to the back of the eye","volume":"303","author":"Patel","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2022.10.011_b0015","unstructured":"Cross R. Without these lipid shells, there would be no mRNA vaccines for COVID-19: Chemical and engineering news; 2021 [Available from: https:\/\/cen.acs.org\/pharmaceuticals\/drug-delivery\/Without-lipid-shells-mRNA-vaccines\/99\/i8."},{"key":"10.1016\/j.ejpb.2022.10.011_b0020","unstructured":"RELEASE FN. FDA Approves First COVID-19 Vaccine 2021 [Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-covid-19-vaccine."},{"key":"10.1016\/j.ejpb.2022.10.011_b0025","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.ejpb.2022.10.011_b0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2014.01.107","article-title":"Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery","volume":"444","author":"Asai","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.ejpb.2022.10.011_b0035","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2022.10.011_b0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.omtn.2021.03.008","article-title":"Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein","volume":"24","author":"Davies","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejpb.2022.10.011_b0045","first-page":"11","article-title":"Cytosolic protein delivery using pH-responsive, charge-reversible lipid nanoparticles","author":"Hirai","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2022.10.011_b0050","article-title":"Protein and mRNA delivery enabled by cholesteryl-based biodegradable lipidoid nanoparticles","volume":"59","author":"Li","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"10","key":"10.1016\/j.ejpb.2022.10.011_b0055","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejpb.2022.10.011_b0060","first-page":"220","article-title":"Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction","author":"Dasa","year":"2015","journal-title":"J. Controlled Release: Off. J. Controll. Release Soc."},{"key":"10.1016\/j.ejpb.2022.10.011_b0065","doi-asserted-by":"crossref","unstructured":"Eloy J, Souza M, Petrilli R, Abriata J, Lee R, Marchetti J. Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery. Colloids and surfaces B, Biointerfaces. 2014;123.","DOI":"10.1016\/j.colsurfb.2014.09.029"},{"key":"10.1016\/j.ejpb.2022.10.011_b0070","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/wnan.46","article-title":"ATP-loaded liposomes for treatment of myocardial ischemia","volume":"1","author":"Hartner","year":"2009","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.ejpb.2022.10.011_b0075","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/17425247.2019.1669558","article-title":"Lipid-based nanoparticle formulations for small molecules and RNA drugs","volume":"16","author":"Ickenstein","year":"2019","journal-title":"Expert Opin Drug Deliv."},{"key":"10.1016\/j.ejpb.2022.10.011_b0080","first-page":"2259","article-title":"Gel-liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy","volume":"24","author":"Jiang","year":"2013","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejpb.2022.10.011_b0085","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s11095-005-8354-x","article-title":"ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction","volume":"22","author":"Verma","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.10.011_b0090","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jconrel.2005.08.029","article-title":"ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model","volume":"108","author":"Verma","year":"2005","journal-title":"J. Controlled Release: Off. J. Controll. Release Soc."},{"issue":"9","key":"10.1016\/j.ejpb.2022.10.011_b0095","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/stem.2856","article-title":"Protective effects of endothelial progenitor cell-derived extracellular mitochondria in brain endothelium","volume":"36","author":"Hayakawa","year":"2018","journal-title":"Stem Cells."},{"issue":"6","key":"10.1016\/j.ejpb.2022.10.011_b0100","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1161\/STROKEAHA.115.009099","article-title":"Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier","volume":"46","author":"Doll","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.ejpb.2022.10.011_b0105","unstructured":"K.M. Dave, D.B. Stolz, M.J. Reynolds, R. Babidhan, D.X. Dobbins, H. Yankello, R. Reddy, Y. Bae, S.S. Shiva, D.S. Manickam, Extracellular Vesicle (EV) Mitochondria and EV\/HSP27 Mixtures Protect the Ischemic Brain Endothelium. bioRxiv. 2022:2021.10.29.466491."},{"issue":"7","key":"10.1016\/j.ejpb.2022.10.011_b0110","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1177\/0271678X19900030","article-title":"Endothelial-specific Crif1 deletion induces BBB maturation and disruption via the alteration of actin dynamics by impaired mitochondrial respiration","volume":"40","author":"Lee","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejpb.2022.10.011_b0115","first-page":"199","article-title":"Regulation of cellular ATP release","volume":"118","author":"Fitz","year":"2007","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"10.1016\/j.ejpb.2022.10.011_b0120","doi-asserted-by":"crossref","first-page":"e69057","DOI":"10.1371\/journal.pone.0069057","article-title":"Extracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation","volume":"8","author":"Orriss","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.ejpb.2022.10.011_b0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1023\/A:1015837321087","article-title":"Adenosine triphosphate liposomes: encapsulation and distribution studies","volume":"7","author":"Guo-Xing","year":"1990","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.011_b0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000129451","article-title":"Liposomal ATP protects the liver from injury during shock","volume":"28","author":"Konno","year":"1996","journal-title":"Eur. Surg. Res."},{"key":"10.1016\/j.ejpb.2022.10.011_b0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0021-9673(00)94549-7","article-title":"Liposomally entrapped adenosine triphosphate: improved efficiency against experimental brain ischaemia in the rat","volume":"440","author":"Laham","year":"1988","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejpb.2022.10.011_b0140","series-title":"ATP-loaded liposomes for targeted treatment in models of myocardial ischemia","first-page":"361","author":"Levchenko","year":"2010"},{"key":"10.1016\/j.ejpb.2022.10.011_b0145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/02652040410001673900","article-title":"Encapsulation of ATP into liposomes by different methods: optimization of the procedure","volume":"21","author":"Liang","year":"2004","journal-title":"J. Microencapsul."},{"issue":"5","key":"10.1016\/j.ejpb.2022.10.011_b0150","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/10611869408996820","article-title":"Liposomes, an interesting tool to deliver a bioenergetic substrate (ATP), in vitro and in vivo studies","volume":"2","author":"Puisieux","year":"1994","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2022.10.011_b0155","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1028","article-title":"Ionizable lipid nanoparticles for in utero mRNA delivery","author":"Riley","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejpb.2022.10.011_b0160","doi-asserted-by":"crossref","DOI":"10.1007\/s12195-020-00619-y","article-title":"Naturally derived membrane lipids impact nanoparticle-based messenger RNA delivery","volume":"13","author":"Kim","year":"2020","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.ejpb.2022.10.011_b0165","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.045765","article-title":"Extracellular vesicle-mediated delivery of CircSCMH1 promotes functional recovery in rodent and nonhuman primate ischemic stroke models","volume":"142","author":"Yang","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejpb.2022.10.011_b0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41434-019-0095-2","article-title":"Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA","volume":"26","author":"Blakney","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejpb.2022.10.011_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2022.10.011_b0180","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2022.10.011_b0185","doi-asserted-by":"crossref","unstructured":"J.A. Kulkarni, P.R. Cullis, R. Van Der Meel, Lipid nanoparticles enabling gene therapies: from concepts to clinical utility. Nucl. Acid Therapeut. 2018. p. 146-57.","DOI":"10.1089\/nat.2018.0721"},{"key":"10.1016\/j.ejpb.2022.10.011_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2020.06.026","article-title":"Lipid nanoparticle technology for therapeutic gene regulation in the liver","author":"Witzigmann","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.10.011_b0195","doi-asserted-by":"crossref","unstructured":"Rehman zu, Zuhorn I, Hoekstra D. How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances. J. Controlled Release: Off. J. Controlled Release Soc. 2012;166.","DOI":"10.1016\/j.jconrel.2012.12.014"},{"key":"10.1016\/j.ejpb.2022.10.011_b0200","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/mt.2009.36","article-title":"Development of Lipidoid\u2013siRNA formulations for systemic delivery to the liver","volume":"17","author":"Akinc","year":"2009","journal-title":"Molecul. Therapy: J. Am. Soc. Gene Therapy"},{"key":"10.1016\/j.ejpb.2022.10.011_b0205","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.ejpb.2022.10.011_b0210","article-title":"Lipid nanoparticle delivery systems for siRNA-based therapeutics","volume":"4","author":"Wan","year":"2014","journal-title":"Drug Del Translat. Res."},{"key":"10.1016\/j.ejpb.2022.10.011_b0215","article-title":"Development of lipidoid nanoparticles for siRNA delivery to neural cells","volume":"24","author":"Khare","year":"2022","journal-title":"The AAPS Journal."},{"key":"10.1016\/j.ejpb.2022.10.011_b0220","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1038\/ncomms5277","article-title":"Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity","volume":"5","author":"Whitehead","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpb.2022.10.011_b0225","unstructured":"Sigma M. Amicon\u00ae Ultra-2 Centrifugal Filter Devices."},{"key":"10.1016\/j.ejpb.2022.10.011_b0230","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","article-title":"Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA","volume":"235","author":"Chen","year":"2016","journal-title":"J. Control. Release"},{"issue":"15","key":"10.1016\/j.ejpb.2022.10.011_b0235","doi-asserted-by":"crossref","first-page":"E3351","DOI":"10.1073\/pnas.1720542115","article-title":"Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles","volume":"115","author":"Yanez Arteta","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.ejpb.2022.10.011_b0240","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s11095-014-1366-7","article-title":"Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small RNAs","volume":"31","author":"Yu","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.10.011_b0245","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/IJN.S123062","article-title":"Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization","volume":"12","author":"Ball","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2022.10.011_b0250","unstructured":"Rapid Analysis of Lipid Nanoparticle Components Using BioAccord LC-MS System [Internet]. Waters Corporation, 2021."},{"key":"10.1016\/j.ejpb.2022.10.011_b0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2021.12.030","article-title":"Evolution of drug delivery systems: From 1950 to 2020 and beyond","volume":"342","author":"Park","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2022.10.011_b0260","series-title":"Characterization of Nanoparticles Intended for Drug Delivery","first-page":"63","article-title":"Zeta Potential Measurement","author":"Clogston","year":"2011"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2022.10.011_b0265","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2011.02.006","article-title":"Skin penetration and deposition of carboxyfluorescein and temoporfin from different lipid vesicular systems: in vitro study with finite and infinite dosage application","volume":"408","author":"Chen","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.011_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejpb.2022.10.011_b0275","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.addr.2009.03.009","article-title":"Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.10.011_b0280","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jcis.2021.11.117","article-title":"Screening of the binding affinity of serum proteins to lipid nanoparticles in a cell free environment","volume":"610","author":"Sebastiani","year":"2022","journal-title":"J. Colloid Interface Sci."},{"issue":"26","key":"10.1016\/j.ejpb.2022.10.011_b0285","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1039\/C6AY00419A","article-title":"A comparison of techniques for size measurement of nanoparticles in cell culture medium","volume":"8","author":"Gollwitzer","year":"2016","journal-title":"Anal. Methods"},{"issue":"48","key":"10.1016\/j.ejpb.2022.10.011_b0290","doi-asserted-by":"crossref","first-page":"e1901551","DOI":"10.1002\/smll.201901551","article-title":"Zwitterion-functionalized detonation nanodiamond with superior protein repulsion and colloidal stability in physiological media","volume":"15","author":"Merz","year":"2019","journal-title":"Small"},{"issue":"7","key":"10.1016\/j.ejpb.2022.10.011_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/ma14071657","article-title":"Controlled formation of a protein corona composed of denatured BSA on upconversion nanoparticles improves their colloidal stability","volume":"14","author":"Shanwar","year":"2021","journal-title":"Materials (Basel)"},{"issue":"7","key":"10.1016\/j.ejpb.2022.10.011_b0300","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1021\/acs.est.6b05539","article-title":"Elemental mass size distribution for characterization, quantification and identification of trace nanoparticles in serum and environmental waters","volume":"51","author":"Zhou","year":"2017","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.ejpb.2022.10.011_b0305","doi-asserted-by":"crossref","unstructured":"I. Degors, C. Wang, Rehman zu, I. Zuhorn, Carriers break barriers in drug delivery: endocytosis and endosomal escape of gene delivery vectors. Acc. Chem. Res. 2019;52.","DOI":"10.1021\/acs.accounts.9b00177"},{"issue":"22","key":"10.1016\/j.ejpb.2022.10.011_b0310","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.biomaterials.2009.03.040","article-title":"Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model","volume":"30","author":"Soenen","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2022.10.011_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2018.09.047","article-title":"Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery","volume":"81","author":"He","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2022.10.011_b0320","first-page":"13","article-title":"Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA","author":"Kulkarni","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejpb.2022.10.011_b0325","first-page":"12","article-title":"On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.011_b0330","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.STR.0000153069.96296.fd","article-title":"Exciting, radical, suicidal","volume":"36","author":"Lo","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ejpb.2022.10.011_b0335","doi-asserted-by":"crossref","unstructured":"A. D'Souza, K.M. Dave, R.A. Stetler, S. Manickam D, Targeting the blood-brain barrier for the delivery of stroke therapies, Adv. Drug Del. Rev. 171 (2021) 332\u201351.","DOI":"10.1016\/j.addr.2021.01.015"},{"key":"10.1016\/j.ejpb.2022.10.011_b0340","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2021.08.038","article-title":"Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells","volume":"338","author":"D'Souza","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2022.10.011_b0345","article-title":"Recent advances in lipid nanoparticle-mediated mRNA therapy","volume":"2019","author":"Maurer","year":"2019","journal-title":"Am. Pharmaceut. Rev."},{"key":"10.1016\/j.ejpb.2022.10.011_b0350","unstructured":"Corporation P. Technical Manual: CellTiter-Glo\u00ae 2.0 Assay. 2021."},{"issue":"6","key":"10.1016\/j.ejpb.2022.10.011_b0355","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/tra.12645","article-title":"Endothelial cell barriers: transport of molecules between blood and tissues","volume":"20","author":"Yazdani","year":"2019","journal-title":"Traffic"},{"key":"10.1016\/j.ejpb.2022.10.011_b0360","doi-asserted-by":"crossref","unstructured":"Engelhardt B, Sorokin L, editors. The blood\u2013brain and the blood\u2013cerebrospinal fluid barriers: function and dysfunction. Seminars in immunopathology; 2009: Springer.","DOI":"10.1007\/s00281-009-0177-0"},{"issue":"46","key":"10.1016\/j.ejpb.2022.10.011_b0365","doi-asserted-by":"crossref","first-page":"1801362","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood\u2013brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"issue":"3\u20134","key":"10.1016\/j.ejpb.2022.10.011_b0370","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","article-title":"A new blood\u2013brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes","volume":"54","author":"Nakagawa","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejpb.2022.10.011_b0375","unstructured":"Corporation P. ATP Assays [Available from: https:\/\/www.promega.com\/resources\/guides\/cell-biology\/atp-assays\/."},{"key":"10.1016\/j.ejpb.2022.10.011_b0380","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/156720208783565645","article-title":"Blood brain barrier in hypoxic-ischemic conditions","volume":"5","author":"Kaur","year":"2008","journal-title":"Curr. Neurovascul. Res."},{"key":"10.1016\/j.ejpb.2022.10.011_b0385","doi-asserted-by":"crossref","first-page":"C88","DOI":"10.1152\/ajpcell.00148.2007","article-title":"Hypoxia effects on cell volume and ion uptake of cerebral microvascular endothelial cells","volume":"294","author":"Brillault","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejpb.2022.10.011_b0390","first-page":"19","article-title":"Hypoxia increases expression of selected blood\u2013brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial monolayers","author":"Ozgur","year":"2022","journal-title":"Fluids Barriers CNS."},{"key":"10.1016\/j.ejpb.2022.10.011_b0395","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2045-8118-12-4","article-title":"Differential responses of blood-brain barrier associated cells to hypoxia and ischemia: a comparative study","volume":"12","author":"Engelhardt","year":"2015","journal-title":"Fluids Barriers CNS."},{"issue":"9","key":"10.1016\/j.ejpb.2022.10.011_b0400","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/jcbfm.2010.29","article-title":"Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation","volume":"30","author":"Lochhead","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejpb.2022.10.011_b0405","doi-asserted-by":"crossref","unstructured":"C.A. Alabi, K.T. Love, G. Sahay, H. Yin, K.M. Luly, R. Langer, D.G. Anderson, Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery, Proc. Natl. Acad. Sci. 110(32) (2013) 12881-6.","DOI":"10.1073\/pnas.1306529110"},{"issue":"7","key":"10.1016\/j.ejpb.2022.10.011_b0410","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle\u2013mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"15","key":"10.1016\/j.ejpb.2022.10.011_b0415","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.gt.3301506","article-title":"On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids","volume":"8","author":"Hafez","year":"2001","journal-title":"Gene Ther."},{"issue":"6","key":"10.1016\/j.ejpb.2022.10.011_b0420","doi-asserted-by":"crossref","first-page":"1805097","DOI":"10.1002\/smll.201805097","article-title":"Branched-tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pH","volume":"15","author":"Hajj","year":"2019","journal-title":"Small"},{"issue":"11","key":"10.1016\/j.ejpb.2022.10.011_b0425","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"issue":"28","key":"10.1016\/j.ejpb.2022.10.011_b0430","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1021\/acs.jpcb.5b02891","article-title":"Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems","volume":"119","author":"Leung","year":"2015","journal-title":"J. Phys. Chem. B"},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.011_b0435","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nano.2012.05.019","article-title":"Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA","volume":"9","author":"Lin","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejpb.2022.10.011_b0440","doi-asserted-by":"crossref","unstructured":"K.T. Love, K.P. Mahon, C.G. Levins, K.A. Whitehead, W. Querbes, J.R. Dorkin, J. Qin, W. Cantley, L.L. Qin, T. Racie, Lipid-like materials for low-dose, in vivo gene silencing, Proc. Natl. Acad. Sci. 107(5) (2010) 1864-9.","DOI":"10.1073\/pnas.0910603106"},{"issue":"2","key":"10.1016\/j.ejpb.2022.10.011_b0445","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2022.10.011_b0450","doi-asserted-by":"crossref","unstructured":"M. Yanez Arteta, T. Kjellman, S. Bartesaghi, S. Wallin, X. Wu, A.J. Kvist, A. Dabkowska, N. Sz\u00e9kely, A. Radulescu, J. Bergenholtz, Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles, Proc. Natl. Acad. Sci. 115(15) (2018) E3351\u2013E60.","DOI":"10.1073\/pnas.1720542115"},{"issue":"5","key":"10.1016\/j.ejpb.2022.10.011_b0455","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ymthe.2004.12.018","article-title":"Nonbilayer phase of lipoplex\u2013membrane mixture determines endosomal escape of genetic cargo and transfection efficiency","volume":"11","author":"Zuhorn","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejpb.2022.10.011_b0460","first-page":"6","article-title":"Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles","author":"Schlich","year":"2021","journal-title":"Bioeng. Transl. Med."},{"issue":"1","key":"10.1016\/j.ejpb.2022.10.011_b0465","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12035-010-8132-6","article-title":"Brain endothelial cell death: modes, signaling pathways, and relevance to neural development, homeostasis, and disease","volume":"42","author":"Rizzo","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejpb.2022.10.011_b0470","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1038\/mtna.2013.65","article-title":"Lipid nanoparticle delivery of siRNA to silence neuronal gene expression in the brain","volume":"2","author":"Rungta","year":"2013","journal-title":"Mol. Therapy Nucleic Acids"},{"issue":"7","key":"10.1016\/j.ejpb.2022.10.011_b0475","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.ejpb.2022.10.011_b0480","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/acs.nanolett.8b01101","article-title":"Lipid nanoparticle formulations for enhanced co-delivery of siRNA and mRNA","volume":"18","author":"Ball","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2022.10.011_b0485","doi-asserted-by":"crossref","unstructured":"Dilliard SA, Cheng Q, Siegwart DJ. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles, Proc. Natl. Acad. Sci. 118(52) (2021) e2109256118.","DOI":"10.1073\/pnas.2109256118"},{"key":"10.1016\/j.ejpb.2022.10.011_b0490","doi-asserted-by":"crossref","unstructured":"M. Frank-Kamenetsky, A. Grefhorst, N.N. Anderson, T.S. Racie, B. Bramlage, A. Akinc, D. Butler, K. Charisse, R. Dorkin, Y. Fan, Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates, Proc. Natl. Acad. Sci. 105(33) (2008) 11915-20.","DOI":"10.1073\/pnas.0805434105"},{"issue":"8","key":"10.1016\/j.ejpb.2022.10.011_b0495","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol. Ther."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122002387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122002387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:51:57Z","timestamp":1760547117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122002387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":99,"alternative-id":["S0939641122002387"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.10.011","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.07.487513","asserted-by":"object"}]},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipidoid nanoparticles increase ATP uptake into hypoxic brain endothelial cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}